Explorer les evidences

7,3 %Among HIV-infected pregnant women exposed to nevirapine (NVP) during the first trimester, the proportion of abortion was 7.3%.

Côte d'IvoireVIH/sidaobservé 2003–2009publié 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

10,9 %10.9% of patients were lost to follow-up during antiretroviral chemoprophylaxis.

Côte d'IvoireVIH/sidaobservé 2000-2007publié 2010Medecine et maladies infectieuseseurope_pmcdocument de 13 observations

17 participantsSeventeen participants had plasma HIV-2 RNA of 50 copies per mL or greater at least once.

Côte d'IvoireVIH/sidapublié 2024The lancet. HIVeurope_pmcdocument de 7 observations

10,2 %Of 551 HIV-2 patients on ART, 10.2% were lost to follow-up during the median time on ART of 2.4 years.

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

29 casesAmong the 128 cases of non-occupational HIV exposure, 29 were due to condom rupture.

Côte d'IvoireVIH/sidaobservé 2000-2007publié 2010Medecine et maladies infectieuseseurope_pmcdocument de 13 observations

10 %Among hospitalized HIV-positive adults in West Africa who died, cerebral toxoplasmosis was a fatal disease in 10% of deaths.

Côte d'Ivoirecerebral toxoplasmosis · VIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797

1,01 aOR_per_50_cells_per_mm3An increase in CD4 cell count between M0 and M24 was associated with being overweight or obese (adjusted odds ratio 1.01 per +50 cells/mm³, 95% confidence interval 1.05–1.13, p = 0.01).

Côte d'IvoireVIH/sidapublié 2016AIDS research and therapyeurope_pmcdocument de 9 observations

75,2 %Among 161 antiretroviral-naïve HIV-HBV coinfected patients in Côte d'Ivoire, 121 (75.2%) had detectable HBV DNA.

Côte d'Ivoirehépatite B · VIH/sidapublié 2016Journal of gastroenterology and hepatologyeurope_pmcdocument de 11 observationsDOI 10.1111/jgh.13156

23 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 23% had never been exposed to HBV.

Côte d'Ivoirehépatite B · VIH/sidapublié 2010Antiviral therapyeurope_pmcdocument de 7 observations

9,7 %Three (9.7%) HIV-2 patients switched to an integrase inhibitor-based regimen.

Côte d'IvoireVIH/sidapublié 2020PloS oneeurope_pmcdocument de 13 observationsDOI 10.1371/journal.pone.0236642

25,7 %Among 1825 HIV-2-infected individuals initiating antiretroviral therapy, 469 (25.7%) were lost to follow-up over the first 24 months.

Côte d'IvoireVIH/sidapublié 2016AIDS (London, England)europe_pmcdocument de 6 observations

5,9 %At month 36, 5.9% of the patients had died.

Côte d'IvoireVIH/sidapublié 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument de 7 observations

465 cells/mm3Patients in the immediate group had a median CD4 count of 465 cells/mm3 at baseline.

Côte d'IvoireVIH/sidapublié 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument de 8 observations

45 %Plasma HIV-1 RNA load was elevated (≥ 5 log₁₀ copies/mL) in 45% of 491 patients.

Côte d'IvoireVIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations

48 patients48 patients (77.4%) were undergoing chemoprophylaxis with cotrimoxazole.

Côte d'IvoireVIH/sidaobservé 1999–2006publié 2010Le Mali medicaleurope_pmcdocument de 17 observations

73 %The survival analysis showed a probability of remaining alive and in care of 73.0% after 72 months.

Côte d'IvoireVIH/sidapublié 2025PloS oneeurope_pmcdocument de 12 observations

45 yearsThe median age of HIV-2-infected individuals initiating antiretroviral therapy was 45 years.

Côte d'IvoireVIH/sidapublié 2016AIDS (London, England)europe_pmcdocument de 6 observations

3 %Dual-type HIV (type 1 plus type 2) was found in 3% of 491 adult HIV patients.

Côte d'IvoireVIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations

80,7 %The survival analysis showed a probability of remaining alive and in care of 80.7% after 48 months.

Côte d'IvoireVIH/sidapublié 2025PloS oneeurope_pmcdocument de 12 observations

42 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 42% had isolated anti-HBc.

Côte d'Ivoirehépatite B · VIH/sidapublié 2010Antiviral therapyeurope_pmcdocument de 7 observations

7 %At month 6, 7% of HIV-1-infected adults on zidovudine + lamivudine + efavirenz had abnormal transaminase value.

Côte d'IvoireVIH/sidaobservé month 6publié 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/01.qai.0000219777.04927.50

1,7 per_100_person_yearsIn patients with pre-ART CD4 cell count 200–349 cells/μL, incidence of mortality was 1.7 per 100 person-years.

Côte d'IvoireVIH/sidapublié 2007AIDS (London, England)europe_pmcdocument de 9 observations

85,7 %Of the 312 patients initially classified as HIV-2, 267 (85.7%) were confirmed as HIV-2.

Côte d'IvoireVIH/sidaobservé 2012publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 8 observations

100 000 copies/mLBaseline HIV-1 RNA <100 000 copies/mL was associated with virologic success.

Côte d'IvoireVIH/sidaobservé baselinepublié 2022Open Forum Infectious Diseaseseurope_pmcdocument de 4 observationsDOI 10.1093/ofid/ofac628

30 deathsIn the Temprano ANRS 12136 trial posttrial phase, 30 deaths occurred among HIV-infected West African adults who were randomized to defer antiretroviral therapy.

Côte d'IvoireVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 6 observations